The US FDA Grants Clearance to ImmersiveTouch’s Augmented Reality Surgical System
Shots:
- The US FDA has granted 510(k) clearance to the company’s augmented reality (AR) technology platform, ImmersiveAR, to be utilized for clinical trials in operating room. Commercialization will begin immediately across the US
- ImmersiveAR enables visualization & interaction with 3D virtual surgical plans from ImmersiveTouch or other similar devices aiding in surgical planning & intraoperative 3D visualization, allowing surgeons to check movements and reduce intraoperative trial & error
- ImmersiveAR can be used to replicate surgical changes to bone and plan final result based on patient’s anatomy, reducing errors & complications
Ref: ImmersiveTouch | Image: ImmersiveTouch
Related News:- The US FDA Grants Marketing Authorization to Virtual Incision’s MIRA Surgical System for Adults Undergoing Colectomy Procedures
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
